Graham Witcomb is a senior analyst at Intelligent Investor owned by InvestSMART Group. Graham has a degree in psychology from the University of Sydney and is a Chartered Financial Analyst charterholder. He previously worked for one of the world's most successful professional gamblers, and joined InvestSMART in 2013 where he focuses on healthcare, insurance and transport infrastructure. This article contains general investment advice only (under AFSL 226435). To unlock Intelligent Investor stock research and buy recommendations, take out a 15-day free membership.
The recession is a double-edge sword for this debt collection agency
As a recession deepens and unemployment rises, the number of unpaid debts increases, but it can be nearly impossible to collect any payments.
Betting giant Tabcorp Holdings’ $300 million jackpot
Lottery ticket sellers Tabcorp and Jumbo have penned a new agreement, but there is one clear victor.
Why you should ignore the coronavirus effect on this medical stock
We're ignoring Integral Diagnostic's 5% share price decline yesterday thanks to coronavirus fears, and looking 10 years out instead.
Cochlear company hit by China’s coronavirus outbreak
The coronavirus outbreak in China is starting to affect Cochlear's bottom line, as Chinese hospitals postpone non-essential surgery.
Why it’s not all bad news for Ramsay Health Care Limited
While Ramsay Health Care Limited had a tough year, its valuation is looking more attractive than it has for a while.
Nanosonics and the risks of a company relying on one customer
This sterilisation device maker has a new product but customer troubles could lead to short-term trouble for the company.
What to do – and what not to do – in a financial crash
A financial crash is a time to avoid panic, ignore the headlines, focus on value ... and buy.
Sirtex faces failed clinical trials and class action lawsuits
Sirtex Medical is not a normal company. It has enough skeletons to fill a graveyard. So what does this mean for shareholders?
Why you should buy shares in oil and tobacco companies
Forget boycotting unethical companies like oil and tobacco producers - it's likely more effective to buy in and change them from the inside.
Why IVF could soon become more affordable in Australia
As IVF become increasingly automated, it seems inevitable that it will follow the cost curve of most technology-intensive processes and get cheaper.
